208 related articles for article (PubMed ID: 22350578)
61. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
Almroth G; Berlin G; Andersson B; Hahn-Zoric M
Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
[TBL] [Abstract][Full Text] [Related]
62. Idiopathic hypertrophic pachymeningitis.
Kupersmith MJ; Martin V; Heller G; Shah A; Mitnick HJ
Neurology; 2004 Mar; 62(5):686-94. PubMed ID: 15007115
[TBL] [Abstract][Full Text] [Related]
63. IgG4 orbital inflammation in a 5-year-old child presenting as an orbital mass.
Kalapesi FB; Garrott HM; Moldovan C; Williams M; Ramanan A; Herbert HM
Orbit; 2013 Apr; 32(2):137-40. PubMed ID: 23480695
[TBL] [Abstract][Full Text] [Related]
64. Optic perineuritis associated with antineutrophil cytoplasmic autoantibody-related hypertrophic pachymeningitis: a case report.
Nakajima H; Yamane K; Kimura F; Oku H
Neurol Sci; 2016 Apr; 37(4):641-3. PubMed ID: 26694175
[No Abstract] [Full Text] [Related]
65. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Ann Rheum Dis; 2006 Nov; 65(11):1484-9. PubMed ID: 16504995
[TBL] [Abstract][Full Text] [Related]
66. [A case of slowly progressive type 1 diabetes mellitus developing myeloperoxidase-specific anti-neutrophil cytoplasmic antibody-associated vasculitis with hypertrophic pachymeningitis manifesting as multiple cranial nerve palsy].
Kurihara Y; Oku K; Suzuki A; Ohsone Y; Handa M; Okano Y
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(6):510-5. PubMed ID: 22214812
[TBL] [Abstract][Full Text] [Related]
67. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
68. [A clinical study of pachymeningitis].
Yoritaka A; Tsukamoto T; Ohta K; Kishida S
No To Shinkei; 2002 Mar; 54(3):235-40. PubMed ID: 11968814
[TBL] [Abstract][Full Text] [Related]
69. Idiopathic hypertrophic cranial pachymeningitis. Report of three cases.
Mamelak AN; Kelly WM; Davis RL; Rosenblum ML
J Neurosurg; 1993 Aug; 79(2):270-6. PubMed ID: 8331412
[TBL] [Abstract][Full Text] [Related]
70. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
71. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Shuai ZW; Lv YF; Zhang MM; Hu ZY
Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
[TBL] [Abstract][Full Text] [Related]
72. [A case of hypertrophic pachymeningitis associated with probable sarcoidosis with increased serum IgG4].
Fujino Y; Saito K; Maezono K; Kasai T; Mizuno T
Rinsho Shinkeigaku; 2019 Jul; 59(7):436-441. PubMed ID: 31243250
[TBL] [Abstract][Full Text] [Related]
73. [Hypertrophic pachymeningitis secondary to IgG4-related disease: case report and review of the literature].
Rodríguez-Castro E; Fernández-Lebrero A; López-Dequidt IA; Rodríguez-Osorio X; López-González FJ; Suárez-Peñaranda JM; Arias M
Rev Neurol; 2015 Oct; 61(7):308-12. PubMed ID: 26411275
[TBL] [Abstract][Full Text] [Related]
74. [Case of cerebral venous thrombosis caused by MPO-ANCA associated hypertrophic pachymeningitis].
Saito T; Fujimori J; Yoshida S; Kaneko K; Kodera T
Rinsho Shinkeigaku; 2014; 54(10):827-30. PubMed ID: 25342019
[TBL] [Abstract][Full Text] [Related]
75. [Two cases of silicosis exhibiting MPO-ANCA associated disorder].
Kourakata H; Saeki T; Miyamura S; Suzuki E; Nakano M; Gejyo F; Arakawa M
Ryumachi; 1999 Dec; 39(6):841-6. PubMed ID: 10695408
[TBL] [Abstract][Full Text] [Related]
76. A Case of MPO-ANCA-Positive Hypertrophic Cranial Pachymeningitis with Spinal Dura Mater Involvement and Cranial Venous Sinus Thrombosis.
Yao S; Liu Y; Sun Q; Qi L; Liu X
Neurol India; 2023; 71(4):807-809. PubMed ID: 37635533
[No Abstract] [Full Text] [Related]
77. [Case report of Wegener's granulomatosis presenting with multiple cranial nerve palsy and hypertrophic cranial pachymeningitis].
Sakurazawa M; Katsumata T; Kunugi S; Katsura K; Sakamoto S; Katayama Y
Rinsho Shinkeigaku; 2007; 47(2-3):85-9. PubMed ID: 17511274
[TBL] [Abstract][Full Text] [Related]
78. The upper thoracic spinal cord compression as the initial manifestation of Wegener's granulomatosis: a case report.
Wang DC; Wei JW; Liu JH; Hu YG
Eur Spine J; 2007 Dec; 16 Suppl 3(Suppl 3):296-300. PubMed ID: 17294055
[TBL] [Abstract][Full Text] [Related]
79. The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients.
Chen H; Zhang W; Jing J; Raza HK; Zhang Z; Zhu J; Liu Y; Cui G; Hua F; Dong L
Neurol Sci; 2019 Feb; 40(2):269-274. PubMed ID: 30377845
[TBL] [Abstract][Full Text] [Related]
80. [MPO-ANCA-associated hypertrophic pachymeningitis with monoclonal gammopathy of undetermined significance: a case report].
Funayama Y; Watanabe G; Tsukita K; Suzuki H; Uenohara H; Suzuki Y
Rinsho Shinkeigaku; 2020 Jul; 60(7):500-503. PubMed ID: 32536662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
